Fully sialylated alpha-chain of complement 4-binding protein (A2160): a novel prognostic marker for epithelial ovarian carcinoma.
| Author | |
|---|---|
| Abstract |
:
Fully sialylated alpha-chain of complement 4-binding protein (A2160) is a member of the glycoprotein family and has recently been identified as a diagnostic biomarker for epithelial ovarian cancer. This study examined the utility of A2160 as a prognostic biomarker for this disease. |
| Year of Publication |
:
2018
|
| Journal |
:
Archives of gynecology and obstetrics
|
| Date Published |
:
2018
|
| ISSN Number |
:
0932-0067
|
| URL |
:
https://dx.doi.org/10.1007/s00404-018-4658-z
|
| DOI |
:
10.1007/s00404-018-4658-z
|
| Short Title |
:
Arch Gynecol Obstet
|
| Download citation |
